Clinical trial
Effects of Saccharomyces Boulardii Probiotics (Bioflor®) on Gut Microbiota in Proton-pump Inhibitor User
NCT07852676 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Saccharomyces Boulardii Probiotics (Bioflor®) on Gut Microbiota in Proton-pump Inhibitor User
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 18, 2024
- Completion date
- September 18, 2025
- Enrollment
- 80 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
dysbiosis, gastroesophageal reflux disease (gerd)